Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-03-12 | Helen H. Hobbs, M.D. AGE: 68 DIRECTOR SINCE: 2011 BOARD COMMITTEES: Governance & Sustainability, Regulatory and Compliance, and Science and Technology (Chair) Investigator, Howard Hughes Medical Institute since 2002, Professor of Internal Medicine and Molecular Genetics and Director of the McDermott Center for Human Growth and Development at the University of Texas Southwestern Medical Center. Scientific Advisor of the Column Group. Member of the American Society for Clinical Investigation and the Association of American Physicians. Elected to the National Academy of Medicine in 2004, the American Academy of Arts and Sciences in 2006, and the National Academy of Sciences in 2007. Received both the Clinical Research Prize (2005) and Distinguished Scientist Award (2007) from the American Heart Association. In 2012, received the inaugural International Society of Atherosclerosis Prize. Received the Pearl Meister Greengard Award (2015) and the Breakthrough Prize in Life Sciences (2015); the Passano Award (2016); the Harrington Prize for Innovation in Medicine (2018); the Lefoulon-Delalande Grand Prize in Science (2018); the Gerald D. Aurbach Award for Outstanding Translational Research (2019); and the Anitschkow Prize (2019). KEY SKILLS & EXPERIENCE: Academia/Medicine & Science/Healthcare & Pharma: Dr. Hobbs’ background reflects significant achievements in academia and medicine. She has served as a faculty member at the University of Texas Southwestern Medical Center for more than 30 years and is a leading geneticist in liver and heart disease, areas in which Pfizer has significant investments and experience. Pfizer benefits from her experience, expertise, achievements and recognition in both medicine and science. |
| 2022-03-17 | Director Nominees: Helen H. Hobbs, M.D. - Academia/Medicine & Science. |
| 2023-03-16 | Helen H. Hobbs, M.D., Age: 70, Director Since: 2011, Board Committees: Governance & Sustainability, Regulatory and Compliance, and Science and Technology (Chair), Total Compensation: $405,948 |
| 2024-03-14 | Helen H. Hobbs, M.D. Age: 71 Director Since: 2011 Board Committees: Governance & Sustainability, Regulatory and Compliance, and Science and Technology (Chair) 2023 Director Compensation Table: Fees Earned or Paid in Cash ($) 185,000, Stock Awards ($) 205,000, All Other Compensation ($) 20,000, Total ($) 410,000 |
Data sourced from SEC filings. Last updated: 2025-07-01